Latest Development Pipeline News

Page 12 of 38
Patrys Limited has expanded its therapeutic portfolio by acquiring Reliis Pty Ltd, adding a proprietary injectable asset targeting delirium with near-term clinical milestones. This strategic move complements its existing biologics platform and strengthens its financial position.
Ada Torres
Ada Torres
30 Jan 2026
Lunnon Metals has secured unconditional status for its Ore Purchase Agreement with Gold Fields and approved mining at Lady Herial, backed by a robust feasibility study projecting strong cash flows. Exploration continues aggressively across its gold and nickel projects in Western Australia.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Micro-X Ltd has secured a historic $3.3 million order for its Rover mobile X-ray units in Malaysia, alongside a $6.2 million capital raise to fuel its expanding medical imaging and security technology pipeline.
Victor Sage
Victor Sage
30 Jan 2026
Lumos Diagnostics reported a strong surge in FebriDx® sales alongside positive FDA feedback, securing full Medicare reimbursement and advancing key clinical studies.
Ada Torres
Ada Torres
29 Jan 2026
Brazilian Rare Earths Limited (BRE) reports a robust scoping study for its Amargosa Bauxite-Gallium Project, alongside a strategic heavy rare earths partnership and a strong cash position to accelerate development.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.
Ada Torres
Ada Torres
29 Jan 2026
St Barbara Limited reports strong feasibility outcomes for its New Simberi Gold Project and Nova Scotia developments, backed by significant strategic investments and regulatory approvals.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Aurum Resources has reported further high-grade gold intercepts at its BMT3 deposit within the Boundiali Gold Project, reinforcing resource confidence ahead of key 2026 milestones. The company is advancing aggressive drilling and development plans backed by a strong cash position.
Maxwell Dee
Maxwell Dee
28 Jan 2026
LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.
Ada Torres
Ada Torres
28 Jan 2026
Tesoro Gold Limited ended December 2025 with a strong cash position of AUD 29.2 million, supporting more than four quarters of exploration and operating activities. The company’s latest cash flow report reveals steady financing inflows amid ongoing investment in its gold exploration projects.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Cyprium Metals has raised A$41 million through an oversubscribed equity placement and entitlement offer to accelerate exploration and production growth at its flagship Nifty Copper Complex and regional projects.
Maxwell Dee
Maxwell Dee
23 Jan 2026
Genesis Energy has reported a robust second-quarter performance for FY26, underpinned by strong hydro generation and record-low thermal output, prompting an upward revision of its full-year earnings guidance. The company’s strategic focus on portfolio flexibility and renewable projects continues to drive margin quality and operational progress.
Maxwell Dee
Maxwell Dee
22 Jan 2026